IP and R&D Spark Newsletter

This month’s Legal Watch opens 2026 with clarity on AI-enabled inventorship and a look back at pivotal 2025 decisions that will shape strategy this year. The USPTO’s AI-Inventorship Guidelines address how AI-assisted inventions should be framed for inventorship, enablement, and disclosure. A concise patent reset reviews last year’s inflection points and “what’s next.” We also track Federal Circuit opinions and orders (Dec 8, 2025) and the weekly patent case summaries (week ending Dec 5, 2025) to spotlight early-year litigation themes and procedural cues.

In Industry News, the EPO launches a Third-Party Observation tool and narrows PACE to the examination stage, while the IP5 Offices extend the Patent Prosecution Highway through 2029, reinforcing global work-sharing. WIPO’s 2025 patent data highlights where filing and enforcement strategies are shifting by country and sector. The EPO–Saudi fast-track route is paused as the PPH pilot reaches its end—an important signal for applicants managing multi-office timelines.

This month’s Techno Spotlight tracks breakthroughs moving from lab to real-world impact:

• Chemicals & Materials: Biodegradable plastic from milk, a protein grown from carrot waste that passed taste tests, first synthesis of a 50-year elusive anti-cancer compound by MIT chemists, and using paper-mill waste for low-cost clean energy.
• Life Sciences: Repurposed drugs slowing pediatric tumor growth; magnetically controlled microrobots enabling programmable microcatheter navigation; RFdiffusion3 from the Baker Lab for next-gen enzyme/protein design; and proton therapy improving survival in head & neck cancer.
• Hi-Tech: Advances in context-aware position encoding for large language models; energy-efficient microelectronic materials; a quantum-forward microchip; and methods for enhancing small language models on complex reasoning tasks.
• Consumer Goods: L’Oréal reinforces strategic investment in Galderma; AB InBev to acquire 85% of BeatBox (US$490M); FrieslandCampina expands whey protein capacity in Wisconsin; Mengniu to launch a GOS probiotic drink.
• Chemical Safety & Regulatory Affairs: The FDA finds insufficient data to confirm PFAS safety in cosmetics; proposes adding Bemotrizinol to the sunscreen monograph; approves Enhertu as first-line therapy for HER2+ breast cancer; the EU Common Data Platform for chemicals goes live; India bans high-dose nimesulide; the FDA approves the first cell-based therapy for severe aplastic anemia; SCCS confirms conditions for micron-sized silver; and health authorities issue rabies vaccine alerts/clarifications.
• Automobile, e-mobility & Mechanical: A historic Italian automaker returns; Changan develops the R05E Wankel rotary engine; Suzuki reveals five concept vehicles; and Volvo’s new font aims to improve screen safety.
• Standard Essential Patents: Access Advance & Via Licensing unite HEVC/VVC pools; Nokia extends Wi-Fi SEP licensing to automotive; Oppo asserts VVC SEPs against Asus in China; and Ericsson expands SEP enforcement across Africa, Asia, and Latin America.

Together, these signals set the tone for 2026—where policy alignment, prosecution pathways, and scale-ready R&D converge to turn roadmaps into measurable impact.

Stay tuned for more innovation shaping the IP and R&D landscape!